Treatment duration of brigatinib in patients enrolled in the international expanded access program (EAP)

被引：0
|
作者：
Lin, M. M. [1 ]
Pan, X. [1 ]
Hou, P. [1 ]
Allen, S. [1 ]
Baumann, P. [1 ]
Hochmair, M. J. [2 ,3 ]
机构：
[1] Millennium Pharmaceut Inc, Cambridge, MA USA
[2] Otto Wagner Spital, Dept Resp & Crit Care Med, Vienna, Austria
[3] Otto Wagner Spital, Ludwig Boltzmann Inst COPD & Resp Epidemiol, Vienna, Austria
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
108O
引用
收藏
页码：42 / 42
页数：1
相关论文
共 50 条
  • [31] The use of nusinersen in the "real world": the UK and Ireland experience with the expanded access program (EAP)
    Scoto, M.
    Manzue, A.
    Main, M.
    Munot, P.
    Tillmann, R.
    Bettolo, C. Marini
    Mayhew, A.
    Muni-Lofra, R.
    White, K.
    Baxter, P.
    Tirupathi, S.
    Douglas, I.
    Douglas, M.
    Macauley, S.
    Childs, A-M
    O'Rourke, D.
    Hartley, L.
    Hughes, I.
    McCullagh, G.
    Spinty, S.
    Madhu, R.
    Gregson, S.
    Gowda, V.
    Wraige, E.
    Horrocks, I.
    Brunklaus, A.
    Di Marco, M.
    Dunne, J.
    Brown, S.
    Mochrie, R.
    Illingworth, M.
    Krishnakumar, D.
    Kirkpatrick, M.
    Ramdas, S.
    Vijayakumar, K.
    Selby, V.
    Kulshrestha, R.
    Willis, T.
    Straub, V.
    Muntoni, F.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S25 - S25
  • [32] NeuroREACH™ Platform for Expanded Access Program (EAP) Trials as the Foundation for Clinical Research of the Future
    Sherman, Alexander
    Podesta, Amanda
    Walker, Jason
    Yu, Hong
    D'Agostino, Derek
    Tarasenko, Natalia
    Sinani, Ervin
    Luppino, Sarah
    Scalia, Jennifer
    Paganoni, Sabrina
    Cudkowicz, Merit
    NEUROLOGY, 2020, 94 (15)
  • [33] Open-label study of pemetrexed alone for chemonaive patients and pre-treated patients with malignant pleural mesothelioma: Outcomes of the International Expanded Access Program (EAP)
    Taylor, P.
    von Pawel, J.
    Castagneto, B.
    Dark, G.
    Marangolo, M.
    van Klaveren, R.
    van Meerbeeck, J.
    Adachi, S.
    Blatter, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [34] IPILIMUMAB (IPI) EXPANDED ACCESS PROGRAM (EAP) FOR PATIENTS (PTS) WITH STAGE III/IV MELANOMA: SAFETY DATA BY SUBGROUPS
    Lawrence, D.
    McDermott, D. F.
    Hamid, O.
    Weber, J. S.
    Wolchok, J. D.
    Richards, J.
    Amin, A.
    Bennett, K.
    Balogh, A.
    Hodi, F. S.
    ANNALS OF ONCOLOGY, 2012, 23 : 368 - 368
  • [35] Cabazitaxel in patients with advanced CRPC after docetaxel failure: Results of expanded program access (EAP) in Spain: Safety and efficacy
    De Velasco, Guillermo
    Anton Aparicio, Luis
    Esteban, Emilio
    Perez, Quionia
    Sanchez-Hernandez, Alfredo
    Perez-Valderrama, Begona
    Batista, Norberto
    Sepulveda, Juan
    Castellano, Daniel E.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] Second-line avelumab treatment of patients (pts) with metastatic Merkel cell carcinoma (mMCC): Experience from a global expanded access program (EAP)
    Walker, John
    Kasturi, Vijay
    Lebbe, Celeste
    Sandhu, Shahneen Kaur
    Grignani, Giovanni
    Hennessy, Meliessa G.
    Hildemann, Steven
    Reed, Josh
    Hariharan, Subramanian
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [37] Toxicity associated to efavirenz in HIV-infected persons enrolled in an expanded access program
    Dona, C
    Soriano, V
    Barreiro, P
    Jiménez-Nácher, I
    González-Lahoz, J
    MEDICINA CLINICA, 2000, 115 (09): : 337 - 338
  • [38] Radium-223 dichloride (Ra-223) in US expanded access program (EAP).
    Vogelzang, Nicholas J.
    Fernandez, Daniel Celestino
    Morris, Michael J.
    Iagaru, Andrei
    Brown, Alan
    Almeida, Fabio
    Sweeney, Christopher
    Smith, Matthew Raymond
    Dicker, Adam
    Wong, Yu-Ning
    Shore, Neal D.
    Bangerter, Keith
    Petrenciuc, Oana
    Sartor, A. Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [39] Open-label study of pemetrexed (P) alone or in combination with a platinum in patients (pts) with peritoneal mesothelioma (PM): results from the international expanded access program (EAP)
    Carteni, G.
    Manegold, C.
    Garcia, G. Martin
    Siena, S.
    Zielinski, C. C.
    Amadori, D.
    Liu, Y.
    Visseren-Grul, C.
    Blatter, J.
    Stahel, R.
    EJC SUPPLEMENTS, 2007, 5 (04): : 379 - 380
  • [40] Use of nivolumab in elderly patients with advanced non-squamous NSCLC: Results from the Italian expanded access program (EAP)
    Migliorino, M. R.
    Gelibter, A.
    Grossi, F.
    Fagnani, D.
    Bordi, P.
    Franchina, T.
    Turci, D.
    Di Lauro, L.
    Cascinu, S.
    Calabro, L.
    Brighenti, M.
    Tedde, N.
    Bearz, A.
    Giusti, S.
    Vasile, E.
    Surico, G.
    Carteni, G.
    Marchetti, P.
    Verderame, F.
    Melotti, B.
    ANNALS OF ONCOLOGY, 2017, 28
12345